News

  • Mar 9, 2022

    Slenyto is now available in Spain!

  • Mar 2, 2022

    Neurim Pharmaceuticals is attending World Sleep Congress 2022, March 11-16, Rome, Italy (Read more)

  • Feb 8, 2022

    Neurim conducted a survey via Brandman Research, assessing the characteristics of insomnia in children with ASD and the distress it causes to the children and their families (Read more)

  • Jan 17, 2022

    Neurim collaborated with Azrieli National Center for Autism and Neurodevelopment Research to assess the burden of Insomnia in children with autism (Read more)

  • Oct 4, 2021

    Slenyto is now available in Portugal!

  • Apr 22, 2020

    Slenyto (PedPRM) is now available in France!

  • Feb 11, 2020

    Slenyto (PedPRM) is now available in Denmark!

  • Jan 27, 2020

    Slenyto (PedPRM) is now also available in Iceland!

  • Jan 14, 2020

    Slenyto (PedPRM) is now available in Switzerland!

  • Sep 18, 2019

    Slenyto (PedPRM) is now available in Norway!

  • Jun 27, 2019

    Neurim Pharmaceuticals attends the ESCAP Congress in Vienna, Austria, 30 June – 2 July 2019

  • May 23, 2019

    Slenyto (PedPRM) is now also available in Italy!

  • Apr 8, 2019

    Neurim Pharmaceuticals attends the EPA Congress in Warsaw, Poland, April 7-9, 2019

  • Apr 3, 2019

    Slenyto (PedPRM) is now also available in UK!

  • Apr 1, 2019

    Slenyto is now available in Finland

  • Jan 27, 2019

    Slenyto is now available in Germany

  • Text size: A A A
  • Circadin
  • Recent news

    • Slenyto is now available in Spain!
    • Neurim Pharmaceuticals is attending World Sleep Congress 2022, March 11-16, Rome, Italy
    • Neurim conducted a survey via Brandman Research, assessing the characteristics of insomnia in children with ASD and the distress it causes to the children and their families
  • Partners

    Partners